Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

Completed

Conditions studied: Developmental Disabilities, Feeding Disorder

In brief

A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.

Key facts

Study ID

NCT02912065

Run by

Société des Produits Nestlé (SPN)

People needed

13

Starts

2015-01-01

Expected to finish

2015-03-01

Last updated by the study team

2016-10-05

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 13 months to < 18 years of age on admission to facility
• Required enteral nutrition to meet 90% or more of their energy needs prior to switch to a Peptide based formula
• Received enteral nutrition with an intact protein formula for a minimum of two weeks prior to a switch to a Peptide based formula
• Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a Peptide based formula
• Have documentation of an assessment of feeding tolerance following the switch to a Peptide based formula
• Formulas received must be indicated for use in children or adults (not infant formulas).

You may not qualify if…

• Recent abdominal surgery, change in tube position/placement (within past 30 days)
• Cow's milk protein allergy
• Any current infections including upper respiratory, viral, gastroenteritis, wound infection.

Where it is running

• Childrens Center for Gastroenterology — Hollywood, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.